TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$13.41M2016: -$32.16M2017: -$69.56M2018: -$90.87M2019: -$106.37M2020: -$136.58M2021: -$267.85M2022: -$458.16M2023: -$515.29M2024: -$534.26M2025: -$440.99M-$440.99M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$440.99M+17.5%
2024-$534.26M-3.7%
2023-$515.29M-12.5%
2022-$458.16M-71.1%
2021-$267.85M-96.1%
2020-$136.58M-28.4%
2019-$106.37M-17.1%
2018-$90.87M-30.6%
2017-$69.56M-116.3%
2016-$32.16M-139.8%
2015-$13.41M—